rs369181536
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_001276345.2(TNNT2):c.764C>T(p.Ala255Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001276345.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251480Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135916
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3
- -
A variant of uncertain significance has been identified in the TNNT2 gene. The c.734 C>T (A245V) variant has been previously reported in association with DCM (Bick et al., 2012; Pugh et al., 2014; Walsh et al., 2017). This variant was first reported in a 69 year-old individual from the offspring cohort of Framingham Heart Study who had features of DCM, including an increased left ventricular diastolic diameter and left atrial diameter, and decreased fractional shortening (Bick et al., 2012). Pugh et al. (2014) also reported this variant in a 53 year-old Caucasian female with a clinical diagnosis and family history of DCM, and no history of skeletal myopathy. Additionally, Chanvat et al. (2016) identified c.734 C>T in their cohort of patients with cardiomyopathy or arrhythmia, although further clinical details describing this patient's specific phenotype were not provided. Thus far, no segregation data are available for any of these published cases. Nevertheless, the c.734 C>T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).The c.734 C>T substitution is located in exon 14, and may be functionally significant at mRNA or protein level. At the mRNA level, c.734 C>T occurs at a nucleotide that is conserved across species, and in silico splice prediction algorithms predict this variant may create a cryptic splice donor site upstream of the natural splice donor site in intron 14 and may impact gene splicing. However, in the absence of functional mRNA studies, the physiological consequence of this variant cannot be precisely determined. At the protein level, A245V is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, although this amino acid substitution occurs at a position that is conserved in mammals, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
- -
- -
Cardiomyopathy Uncertain:2
- -
This missense variant replaces alanine with valine at codon 245 of the TNNT2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with dilated cardiomyopathy (PMID: 24503780). This variant has also been reported in an individual from a cohort of participants that were not pre-selected for a personal or family history of cardiovascular disorders (PMID: 22958901). This variant has been identified in 1/251480 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
proposed classification - variant undergoing re-assessment, contact laboratory -
Primary familial dilated cardiomyopathy Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.A245V variant (also known as c.734C>T), located in coding exon 13 of the TNNT2 gene, results from a C to T substitution at nucleotide position 734. The alanine at codon 245 is replaced by valine, an amino acid with similar properties. This variant has been reported in an individual in a dilated cardiomyopathy (DCM) cohort, but clinical details were limited (Pugh TJ et al. Genet. Med., 2014 Aug;16:601-8; Walsh R et al. Genet. Med., 2017 02;19:192-203). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1D;C1861864:Hypertrophic cardiomyopathy 2;C2676271:Cardiomyopathy, familial restrictive, 3 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 245 of the TNNT2 protein (p.Ala245Val). This variant is present in population databases (rs369181536, gnomAD 0.0009%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 24503780). ClinVar contains an entry for this variant (Variation ID: 177873). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TNNT2 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at